CliffBio
small molecule

DROSPIRENONE AND ETHINYL ESTRADIOL

DROSPIRENONE; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameDROSPIRENONE AND ETHINYL ESTRADIOL
Active ingredientDROSPIRENONE; ETHINYL ESTRADIOL
Strength3MG;0.03MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalSeptember 2016
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.